Amgen Inc. (AMGN) vs Bristol-Myers Squibb Company (BMY)
A side-by-side comparison of Amgen Inc. and Bristol-Myers Squibb Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 8, 2026. Differences are shown without an overall score or investment verdict.
AMGN
Amgen Inc.
$395.29HealthcareDelayed quote: Sep 8, 2026, 12:25 PM EDT
BMY
Bristol-Myers Squibb Company
$65.30HealthcareDelayed quote: Sep 8, 2026, 12:25 PM EDT
Total return — AMGN vs BMY
growth of $100 · dividends reinvested · last 10yAMGN +242.3% (+13.1%/yr)BMY +68.9% (+5.4%/yr)AMGN compounded faster over this window
AMGN BMY
AMGN vs BMY: by the numbers
- •AMGN is the larger company ($213.34B vs $133.38B market cap).
- •BMY trades at the lower trailing earnings multiple (14.72 vs 27.17 P/E), one valuation lens rather than an overall verdict.
- •AMGN converts more revenue to profit (22.93% vs 18.87% net margin).
- •AMGN grew revenue faster over the past five years (8.39% vs 2.08% CAGR).
- •BMY pays the higher dividend yield (3.76% vs 2.24%).
Metrics side by side
Valuation
| Metric | AMGN | BMY |
|---|---|---|
| P/E ratio | 27.17 | 14.72 |
| Forward P/E | 18.95 | 9.64 |
| P/S ratio | 6.24 | 2.78 |
| P/B ratio | 20.35 | 6.13 |
| EV / EBITDA | 17.35 | 10.11 |
| FCF yield | 4.28% | 8.36% |
Profitability
| Metric | AMGN | BMY |
|---|---|---|
| Gross margin | 72.65% | 70.16% |
| Operating margin | 33.18% | 28.27% |
| Net margin | 22.93% | 18.87% |
| ROE | 74.80% | 41.59% |
| ROIC | 14.22% | 15.47% |
Dividends
| Metric | AMGN | BMY |
|---|---|---|
| Dividend yield | 2.24% | 3.76% |
| Payout ratio | 60.91% | 55.29% |
Growth (annualized)
| Metric | AMGN | BMY |
|---|---|---|
| Revenue CAGR (5Y) | 8.39% | 2.08% |
| EPS CAGR (5Y) | 2.94% | 9.38% |
| FCF CAGR (5Y) | -3.91% | -0.95% |
| Total return CAGR (5Y) | 17.67% | 4.56% |
Frequently asked
- Which has the lower trailing P/E, AMGN or BMY?
- BMY has the lower trailing P/E: AMGN trades at 27.17 and BMY at 14.72. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, AMGN or BMY?
- Over the past five years, AMGN grew revenue faster — AMGN at a 8.39% CAGR versus BMY at 2.08%.
- Does AMGN or BMY pay a bigger dividend?
- AMGN yields 2.24% and BMY yields 3.76% based on trailing dividends and the latest price.
- Is AMGN or BMY more profitable?
- AMGN runs the higher net margin — AMGN at 22.93% versus BMY at 18.87%.
- How have AMGN and BMY total returns compared?
- Over the past 10 years, AMGN delivered 13.24% and BMY delivered 5.37% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Amgen P/E ratioBristol-Myers Squibb P/E ratioAmgen dividend yieldBristol-Myers Squibb dividend yieldAmgen ROEBristol-Myers Squibb ROEAmgen operating marginBristol-Myers Squibb operating marginAmgen revenue growthBristol-Myers Squibb revenue growthAmgen free cash flowBristol-Myers Squibb free cash flow
Amgen & Bristol-Myers Squibb appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 8, 2026.